Latest News

Quotient Sciences’ Modeling and Simulation (M&S) team has recently completed qualification of GastroPlus, the software they use for physiologically based pharmacokinetic (PBPK) modeling. This 2-year project reflects Quotient Science...

Quotient Sciences has completed major investments and expansions at its Nottingham, UK and Reading, UK, facilities to support the delivery of fully integrated drug development programs.Company increases laboratory and clinical capacity to m...

Gareth Jenkins, VP Science and Technology, Candidate Development Services at Quotient Sciences, Contributes to Chemistry Today Panel Discussion on Flow Chemistry. Read Gareth's contributions to this panel discussion with Chemistry Toda...

Partnership further expedites Ensysce’s development pipelineNOTTINGHAM, UK; August 31, 2022 – Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC)(OTC PINK:ENSCW), a clinical-stage biotech company applyin...

NOTTINGHAM, UK; August 24,2022 – Quotient Sciences, a drug development and manufacturing accelerator, has completed a £1.5 million expansion of its early development and manufacturing facility in Reading, UK.The investment...